 Connection
Martin McCarter to Combined Modality Therapy
This is a "connection" page, showing publications Martin McCarter has written about Combined Modality Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.494 |
|
|
|
-
Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
Score: 0.123
-
Stewart CL, Gleisner A, Halpern A, Ibrahim-Zada I, Luna RA, Pearlman N, Gajdos C, Edil B, McCarter M. Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia. Ann Surg Oncol. 2018 Mar; 25(3):655-659.
Score: 0.122
-
Wei AZ, Chen LN, Orloff M, Ariyan CE, Asgari M, Barker CA, Buchbinder E, Chandra S, Couts K, Frumovitz MM, Futreal A, Gershenwald JE, Hanna EY, Izar B, LeBlanc AK, Leitao MM, Lipson EJ, Liu D, McCarter M, McQuade JL, Najjar Y, Rapisuwon S, Selig S, Shoushtari AN, Yeh I, Schwartz GK, Guo J, Patel SP, Carvajal RD. Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment Cell Melanoma Res. 2023 11; 36(6):542-556.
Score: 0.046
-
McCarter MD, Quan SH, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget's disease. Dis Colon Rectum. 2003 May; 46(5):612-6.
Score: 0.044
-
Chapman BC, Weyant M, Hilton S, Hosokawa PW, McCarter MD, Gleisner A, Nader ND, Gajdos C. Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States. Ann Thorac Surg. 2019 11; 108(5):1535-1542.
Score: 0.034
-
Ripley RT, Gajdos C, Reppert AE, Macdermott T, McCarter MD, Pearlman NW. Sequential radiofrequency ablation and surgical debulking for unresectable colorectal carcinoma: thermo-surgical ablation. J Surg Oncol. 2013 Feb; 107(2):144-7.
Score: 0.021
-
Gajdos C, Macdermott T, McCarter MD, Pearlman NW. Combined thermal-surgical ablation of locally advanced abdominopelvic malignancies. Ann Surg Oncol. 2011 May; 18(5):1267-73.
Score: 0.019
-
Olsen CC, Schefter TE, Chen H, Kane M, Leong S, McCarter MD, Chen Y, Mack P, Eckhardt SG, Stiegmann G, Raben D. Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy. Am J Clin Oncol. 2009 Apr; 32(2):115-21.
Score: 0.017
-
Thomison J, McCarter M, McClain D, Golitz LE, Goldenberg G. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate. J Cutan Pathol. 2008 Nov; 35(11):1003-6.
Score: 0.016
-
Pearlman NW, McCarter MD, Escober G, MacDermott T. Combined radiofrequency-surgical debulking of advanced abdomino-pelvic tumors. Am J Surg. 2006 Dec; 192(6):833-6.
Score: 0.014
-
Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006; 45(7):848-55.
Score: 0.013
-
Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2. Oncology (Williston Park). 2005 Jun; 19(7):830, 835-6, 838 passim.
Score: 0.013
-
Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1. Oncology (Williston Park). 2005 May; 19(6):775-8, 783-4, 788 passim.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|